Obesity‐induced upregulation of NR2F6 promotes the expression of CD36 in the liver, thereby facilitating fatty acid uptake and triglyceride retention, contributing to NAFLD and insulin resistance. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.